Alerts will be sent to your verified email
Verify Email
WINDLAS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Windlas Biotech Limited is a leading pharmaceutical CDMO company in India, offering a wide range of development and manufacturing services of high-quality and cost-effective products globally, along with branded products in trade generics and OTC markets.
Windlas Biotech major competitors are Bliss GVS Pharma, Shukra Pharma, TTK Healthcare, Beta Drugs, Jagsonpal Pharma, Syncom Formulations, Hester Biosciences.
Market Cap of Windlas Biotech is ₹1,661 Crs.
While the median market cap of its peers are ₹1,536 Crs.
Windlas Biotech seems to be less financially stable compared to its competitors.
Altman Z score of Windlas Biotech is 6.45 and is ranked 6 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug Nov | Mar Jun Sep Dec | Sep Dec | |||||||||||||||
| Investor Presentation | May Aug Nov | Mar Jun Sep Dec | Feb Mar May Jun Sep Dec | Feb Mar May Jun Aug Sep Nov | Jun Sep Dec | |||||||||||||
| Conference Call | Mar Jun Nov | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Sep Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
